D-0333-2026 Class II Ongoing

Recalled by Fresenius Kabi Compounding, LLC — Canton, MA

FDA drug recall D-0333-2026 was initiated by Fresenius Kabi Compounding, LLC on Feb 5, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 1057 bags.

Recall details

Product Type
Drugs
Report Date
Feb 18, 2026
Initiation Date
Feb 5, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1057 bags

Product description

acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For Intravenous Use, Single-Use Bag, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-035-56

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

US Nationwide.

Code information

Lot # C274-000049124, Exp Date: 28-Feb-26.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0333-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0333-2026. Report a data issue: hello@regdatalab.com.